Skip to search formSkip to main contentSkip to account menu

Theramex

National Institutes of Health

Related topics

Related topics

1 relation

Broader (1)

testosterone enanthate

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2014
2014
Challenges for the Development of Bone-Forming Agents in Europe
2014
2014
SAT0463 Effect of Eight Years of Denosumab Treatment in Postmenopausal Women with Osteoporosis: Five-Year Results from the Freedom Extension
Background Denosumab (DMAb) is an approved therapy for the treatment of postmenopausal women with osteoporosis at increased risk… 
2013
2013
OP0248 Inhibition of Sclerostin with Romosozumab in Postmenopausal Women with Low Bone Mineral Density: Phase 2 Trial Results
Background In preclinical studies, administration of antibodies that neutralize sclerostin results in increased bone mass and… 
2013
2013
SAT0341 Strontium Ranelate Improves Osteoarthritis Symptoms Compared to Placebo in Patients with Knee OA - The Sekoia Study
Objectives In SEKOIA, strontium ranelate 2g/day (SrRan) has shown a structure-modifying activity with significant symptomatic… 
2010
2010
Freedom Trial First-Year Extension: Results from 4 Years of Denosumab Exposure in Women with Postmenopausal Osteoporosis
Aims: To investigate the long-term efficacy and safety of denosumab (DMAb) for the treatment of postmenopausal women with… 
2010
2010
Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women.
2009
2009
Expression différentielle de la GPx5, un membre de la famille multigénique des glutathion peroxydases de mammifères
En utilisant des approches moleculaires variees, nous avons montre que le gene gpx5 possede au moins trois transcrits dans l… 
2005
2005
[Methodology of the inquiry MISSION (menopause, breast cancer risk, morbidity and prevalence)].
OBJECTIVE The ambition of this article is to detail and to explain the methodology of the study named MISSION (Menopause: breast… 
1997
1997
[Comparative study of the acceptability of a new estradiol Tx 11323 (A) gel and a transdermal matrix system].
OBJECTIVE to compare the acceptability of a new estradiol gel TX 11323 (A) and a transdermal matrix system. METHOD this… 
1995
1995
Demand for quality-of-life studies is increasing
O ver the last decade, quality of life (QOL) has become an important outcome in clinical trials and in research on the quality of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)